StockIQ.techIDEXX Laboratories Inc. (IDXX) Stock Analysis
Free AI-powered analysis and research for IDEXX Laboratories Inc. stock
Sector: Healthcare
IDXX snapshot
Data as of 3 Nov 2026 close. Updated daily.
IDEXX Laboratories Inc. scores 71/100 on StockIQ's model, which reads as positive signals overall. The price is above its 200-day average and at 64% of its 52-week range, down 6.8% over the past year. Latest reported figures show a profit margin of 25.0%, return on equity of 74.2% and revenue growth of +9.7%.
What is driving the score
- Strong Uptrend: +12
- MACD Bullish: +8
- High P/E (38.7): -10
- Excellent Profit Margin (25.0%): +10
- Weak Liquidity (1.17 Current Ratio): -5
- Excellent ROE (74.2%): +8
- High P/B (26.96): -5
- Strong Long-term Uptrend: +8
- Underperforming (-6.8% over 1 year): -5
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full IDXX report
IDEXX Laboratories Inc. (IDXX) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze IDXX Now →📰 Latest Update
Idexx Laboratories (IDXX) Crossed Above the 200-Day Moving Average: What That Means for Investors
Tue, November 3, 2026 at 1:30 PM UTC 4 min read
Idexx Laboratories (IDXX) has recently surpassed the 200-day moving average, indicating a potential long-term bullish trend. The stock has risen 27.4% over the past four weeks, and positive earnings estimate revisions support this bullish outlook, with no estimates declining and two increasing in the last two months. Investors may want to monitor IDXX for further gains based on these technical indicators and earnings revisions.